Executive Director, the Phoenix Bioscience Core
Scarlett Spring, Executive Director of the Phoenix Bioscience Core, a life sciences innovation district in the heart of Downtown Phoenix.?Scarlett is a 20+ pharmaceutical year executive with Fortune 100 companies Merck, and AstraZeneca as well as a Board Member of AVEO Oncology, a recent acquisition by LG Chem company.? Scarlett is Co-Founder and Board Chair of TapRoot Interventions & Solutions, creators of Ella®, the first personalized care management platform for persons with Alzheimer’s disease, dementia, and mental illness, providing suggested interventions for 60 of the most common caregiving challenges. In prior roles, she served as President and Chief Commercial Officer of VisionGate, a vertically integrated oncology pharmaceutical and diagnostics company focused on the prevention of cancer deaths through early cancer prevention.
Currently, Scarlett serves as a Board Director for the Republic Bank of Arizona and chair of the Asset and Liabilities Committee. She is also a member of the volunteer board, the Arizona Sports and Tourism Association serving as Chair of the Finance Committee, a member of Arizona’s Bioscience Roadmap Steering Committee, and Co-Chair of the Flinn Risk Capital Committee.